SCLX Competitors & Alternatives
Compare Scilex Holding Company Common Stock with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
SCLX
Main Stock$7.01
Tradestie Score
52
Market Cap
$143.84M
Revenue Growth
-0.7%
Analyst Upside
+6890.0%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$342.57
|
$160.70B | 24.9 | 62 | Compare |
|
GILD
Gilead Sciences Inc
|
$133.36
|
$137.92B | 20.3 | 60 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$811.46
|
$46.96B | 43.3 | 63 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$109.61
|
$24.57B | - | 60 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$186.57
|
$22.61B | 20.2 | 63 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$130.62
|
$13.59B | 28.5 | 62 | Compare |
|
EXEL
Exelixis Inc
|
$45.26
|
$11.09B | 16.1 | 66 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$55.77
|
$10.74B | - | 59 | Compare |
|
QGEN
QIAGEN N.V.
|
$41.33
|
$10.04B | 20.2 | 63 | Compare |
|
TECH
Bio-Techne Corp.
|
$61.99
|
$9.33B | 111.8 | 54 | Compare |
More SCLX Analysis
Data updated: Apr 21, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry